Equity capital markets in the pharmaceutical and biotech industry
Our capital markets team invites you to attend a breakfast seminar, where we will hear from a distinguished panel of experts on the issues and opportunities faced when listing early stage pharmaceutical and biotech companies on the London Stock Exchange.
- Mitesh Patelia, Partner, Crowe Clark Whitehill
- Vadim Alexandre, Managing Director, Northland Capital Partners
- Dr Dmitry Kuzmin, Managing Partner, 4BIO Capital
- James Wilkinson, Partner, Reed Smith
- Fiona McFarlane, Senior Associate, Reed Smith
There is no cost to attend this event.
For further information, please contact Candi Percival.
London EC2A 2RS